Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction

Multiple myeloma (MM) is an aggressive cancer characterised by malignancy of the plasma cells and a rising global incidence. The gold standard for optimum response is aggressive chemotherapy followed by autologous stem cell transplantation (ASCT). However, majority of the patients are above 60 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Manav, Bakhai, Viral, Trivedi, Jash, Mishra, Adarsh, De Andrés, Fernando, LLerena, Adrián, Sharma, Rohit, Nair, Sujit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478452/
https://www.ncbi.nlm.nih.gov/pubmed/36103755
http://dx.doi.org/10.1016/j.tranon.2022.101532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478452/
https://www.ncbi.nlm.nih.gov/pubmed/36103755
http://dx.doi.org/10.1016/j.tranon.2022.101532

Ejemplares similares